These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33832059)

  • 1. A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients.
    Wu B; Wang Z; Lin N; Yan X; Lv Z; Ying Z; Ye Z
    Medicine (Baltimore); 2021 Apr; 100(14):e24118. PubMed ID: 33832059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes.
    Feng L; Chen Y; Mei X; Wang L; Zhao W; Yao J
    Cancer Biother Radiopharm; 2024 Sep; 39(7):517-531. PubMed ID: 38512709
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
    Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
    Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Prognostic RBPs in Osteosarcoma.
    Li B; Fang L; Wang B; Yang Z; Zhao T
    Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
    Rothzerg E; Xu J; Wood D; Kõks S
    Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A four-lncRNA risk signature for prognostic prediction of osteosarcoma.
    Liu H; Chen C; Liu L; Wang Z
    Front Genet; 2022; 13():1081478. PubMed ID: 36685868
    [No Abstract]   [Full Text] [Related]  

  • 9. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
    Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
    Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis.
    Teng JS; Wang Y
    Sci Rep; 2024 Jun; 14(1):13401. PubMed ID: 38862526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a five-mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor.
    Lin XD; Wu YP; Chen SH; Sun XL; Ke ZB; Chen DN; Li XD; Lin YZ; Wei Y; Zheng QS; Xu N; Xue XY
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1032. PubMed ID: 31701684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
    Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
    J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 17. The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma.
    Ying T; Dong JL; Yuan C; Li P; Guo Q
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.
    Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP
    J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma.
    Yuan J; Yuan Z; Ye A; Wu T; Jia J; Guo J; Zhang J; Li T; Cheng X
    Front Immunol; 2021; 12():758845. PubMed ID: 34691083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.